Cytori to Webcast at the JMP Securities Healthcare Conference on July 10,
JMP Securities Healthcare Conference 2013
SAN DIEGO -- July 3, 2013
Cytori Therapeutics, Inc. (NASDAQ: CYTX) will present and provide a webcast of
their corporate presentation at JMP Securities Healthcare Conference at 12:30
PM (ET) on Wednesday, July 10, 2013 in New York.
The webcast may be accessed under "Webcasts" in the Investor Relations section
of the Company's website. The webcast can be accessed live and will be
available for replay after the presentation on the Company's website.
Cytori Therapeutics, Inc. is developing cell therapies based on autologous
adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and
repair soft tissue defects. Our scientific data suggest ADRCs improve blood
flow, moderate the inflammatory response and keep tissue at risk of dying
alive. As a result, we believe these cells can be applied across multiple
"ischemic" conditions. These therapies are made available to the physician and
patient at the point-of-care by Cytori's proprietary technologies and
products, including the Celution® system product family. www.cytori.com
Cytori Therapeutics, Inc.
Press spacebar to pause and continue. Press esc to stop.